The binding specificity of cetuximab-IR700 dye conjugate (anti-EGFR-IR700 antibody conjugate; CTX-IR700) to epidermal growth factor receptor (EGFR) was evaluated in vitro on BxPC-3 pancreatic adenocarcinoma tumor cells by flow cytometry. This evidence concerns the gene EGFR and pancreatic adenocarcinoma.